BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3310630)

  • 21. Healing of erosive esophagitis with sucralfate and cimetidine: influence of pretreatment lower esophageal sphincter pressure and serum pepsinogen I levels.
    Ros E; Toledo-Pimentel V; Bordas JM; Grande L; Lacima G; Segu L
    Am J Med; 1991 Aug; 91(2A):107S-113S. PubMed ID: 1882895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recurrence of reflux esophagitis can be prevented with maintenance therapy with sucralfate].
    Tytgat GN; Koelz HR; Vosmaer GD
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2432-7. PubMed ID: 8524425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study.
    Ros E; Pujol A; Bordas JM; Grande L
    Scand J Gastroenterol Suppl; 1989; 156():49-55. PubMed ID: 2740842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sucralfate tablets 1 g twice a day for the prevention of duodenal ulcer recurrence.
    Bynum TE; Koch GG
    Am J Med; 1989 Jun; 86(6A):127-32. PubMed ID: 2660555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sucralfate versus cimetidine in reflux oesophagitis. A double-blind clinical study.
    Elsborg L; Jørgensen F
    Scand J Gastroenterol; 1991 Feb; 26(2):146-50. PubMed ID: 2011701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
    Graham DY; Patterson DJ
    Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
    Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R
    Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturnal dosage regimen of sucralfate in maintenance treatment of gastric ulcer.
    Marks IN; Girdwood AH; Wright JP; Newton KA; Gilinsky NH; Kalvaria I; Burns DG; O'Keefe SJ; Tobias R; Lucke W
    Am J Med; 1987 Sep; 83(3B):95-8. PubMed ID: 3310633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sucralfate versus cimetidine in the treatment of reflux esophagitis, with special reference to the esophageal motor function.
    Jørgensen F; Elsborg L
    Am J Med; 1991 Aug; 91(2A):114S-118S. PubMed ID: 1882896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine.
    Breen KJ; Desmond PV; Whelan G
    Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophagitis: clinical and endoscopic assessment of sucralfate therapy.
    Chopra BK; Kazal HL; Mittal PK; Sibia SS
    Indian J Med Sci; 1991 Mar; 45(3):55-7. PubMed ID: 1916972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis.
    Shenep JL; Kalwinsky DK; Hutson PR; George SL; Dodge RK; Blankenship KR; Thornton D
    J Pediatr; 1988 Oct; 113(4):758-63. PubMed ID: 3050005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the clinical efficacy of ranitidine and sucralfate in reflux esophagitis.
    Chopra BK; Kazal HL; Mittal PK; Sibia SS
    J Assoc Physicians India; 1992 Jul; 40(7):439-41. PubMed ID: 1484022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sucralfate gel versus placebo in patients with non-erosive gastro-oesophageal reflux disease.
    Simon B; Ravelli GP; Goffin H
    Aliment Pharmacol Ther; 1996 Jun; 10(3):441-6. PubMed ID: 8791975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.
    Caldwell JR; Roth SH; Wu WC; Semble EL; Castell DO; Heller MD; Marsh WH
    Am J Med; 1987 Sep; 83(3B):74-82. PubMed ID: 3310631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of reflux esophagitis with sucralfat].
    Weiss W; Brunner H; Büttner GR; Gabor M; Miederer S; Mittelstaedt A; Olbermann M; Schwamberger K; Witzel L
    Dtsch Med Wochenschr; 1983 Nov; 108(45):1706-11. PubMed ID: 6354663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial.
    Baldi F; Bianchi Porro G; Dobrilla G; Iascone C; Lobello R; Marzio L; Sabbatini F; Tittobello A; Verme G
    J Clin Gastroenterol; 1988 Dec; 10(6):614-8. PubMed ID: 3068300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of sucralfate with placebo in the treatment of esophageal ulcers following therapeutic endoscopic sclerotherapy of esophageal varices--a prospective controlled randomized trial.
    Paquet KJ; Koussouris P; Keinath R; Rambach W; Kalk JF
    Am J Med; 1991 Aug; 91(2A):147S-150S. PubMed ID: 1882901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sucralfate versus placebo in treatment of non-ulcer dyspepsia.
    Kairaluoma MI; Hentilae R; Alavaikko M; Kellosalo J; Stahlberg M; Jalovaara P; Olsen M; Jaervensivu P; Laitinen S
    Am J Med; 1987 Sep; 83(3B):51-5. PubMed ID: 3310629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sucralfate therapy and reflux esophagitis: an overview.
    Orlando RC
    Am J Med; 1991 Aug; 91(2A):123S-124S. PubMed ID: 1882898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.